Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News United Therapeutics Corp UTHR

Healthcare Biotechnology
United Therapeutics Corporation is a pharmaceutical company. It markets and sells commercial therapies to treat pulmonary arterial hypertension (PAH): Tyvaso DPI (treprostinil) Inhalation Powder (Tyvaso DPI); Tyvaso (treprostinil) Inhalation Solution (nebulized Tyvaso), which includes the Tyvaso Inhalation System; Remodulin (treprostinil) Injection (Remodulin); Orenitram (treprostinil) Extended... see more

Recent & Breaking News (NDAQ:UTHR)

United Therapeutics Announces INCREASE Study Of Tyvaso® Meets Primary And All Secondary Endpoints

PR Newswire February 24, 2020

United Therapeutics Corporation to Report Fourth Quarter and Full Year 2019 Financial Results Before the Market Opens on Wednesday, February 26, 2020

PR Newswire February 19, 2020

United Therapeutics Defeats Preliminary Injunction Motion In Litigation With Sandoz And RareGen

PR Newswire February 4, 2020

United Therapeutics Announces Study of Unituxin® (dinutuximab) for Small Cell Lung Cancer Did Not Meet Primary Endpoint

PR Newswire February 3, 2020

United Therapeutics Corporation To Present At The 38th Annual J.P. Morgan Healthcare Conference

PR Newswire January 6, 2020

United Therapeutics Corporation Reports Third Quarter 2019 Financial Results

PR Newswire October 30, 2019

United Therapeutics Corporation to Report Third Quarter 2019 Financial Results Before the Market Opens on Wednesday, October 30, 2019

PR Newswire October 23, 2019

United Therapeutics Announces FDA Approval Of Updated Label For Orenitram Reflecting Results Of FREEDOM-EV Study

PR Newswire October 21, 2019

United Therapeutics Announces FDA Acceptance Of Trevyent New Drug Application For Review

PR Newswire September 11, 2019

iBio Inks 3D Bioprinting Agreement

GlobeNewswire August 19, 2019

United Therapeutics Corporation To Present At 2019 Wedbush PacGrow Healthcare Conference

PR Newswire August 6, 2019

United Therapeutics Corporation Reports Second Quarter 2019 Financial Results

PR Newswire July 31, 2019

United Therapeutics Corporation to Present at Goldman Sachs 40th Annual Global Healthcare Conference

PR Newswire June 5, 2019

United Therapeutics Corporation To Present at Jefferies 2019 Healthcare Conference

PR Newswire May 28, 2019

United Therapeutics And DEKA Announce FDA Clearance Of The Unity Subcutaneous Delivery System For Remodulin®

PR Newswire May 7, 2019

United Therapeutics Corporation Reports First Quarter 2019 Financial Results

PR Newswire May 1, 2019

United Therapeutics Announces FDA Approval Of XPS(TM) And Steen Solution(TM) Used To Perform Centralized Ex-Vivo Lung Perfusion Services

PR Newswire April 29, 2019

United Therapeutics Corporation To Report First Quarter 2019 Financial Results Before The Market Opens On Wednesday, May 1, 2019

PR Newswire April 24, 2019

United Therapeutics Issues Statement In Response To Meritless Lawsuit

PR Newswire April 17, 2019

A Peek Into The Markets: US Stock Futures Signal Lower Start On Wall Street

Benzinga.com  April 8, 2019